SCHEMBL7279148

SCHEMBL7279148

N[C@@H](Cc1cccc(NC(=O)CCl)c1)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 3/20 0.64
▸ NOS1 P29475 3/20 0.64
▸ NOS2 P35228 3/20 0.64
▸ NPSR1 Q6W5P4 1/20 0.55
▸ SLC7A5 Q01650 6/20 0.53
▸ PTGS1 P23219 2/20 0.53
▸ ALPI P09923 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ XIAP P98170 1/20 0.53
▸ GRIA2 P42262 1/20 0.51
▸ MITF O75030 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ SLC1A2 P43004 2/20 0.47
▸ SLC1A1 P43005 2/20 0.47
▸ CASR P41180 1/20 0.47
▸ SLC1A3 P43003 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7279140 1.00 NOS3 (0.64) NOS3NOS1NOS2NPSR1SLC7A5
SCHEMBL22690013 0.89 NOS3 (0.62) NOS3NOS1NOS2SLC7A5PTGS1
SCHEMBL22690011 0.89 NOS3 (0.62) NOS3NOS1NOS2SLC7A5PTGS1
SCHEMBL22689884 0.87 NOS3 (0.59) NOS3NOS1NOS2SLC7A5PTGS1
SCHEMBL22689885 0.87 NOS3 (0.59) NOS3NOS1NOS2SLC7A5PTGS1
SCHEMBL29550581 0.87 NOS3 (0.59) NOS3NOS1NOS2SLC7A5PTGS1
SCHEMBL22442158 0.86 NOS3 (0.68) NOS3NOS1NOS2SLC7A5PTGS1
SCHEMBL22442159 0.86 NOS3 (0.68) NOS3NOS1NOS2SLC7A5PTGS1
SCHEMBL16861149 0.86 NOS3 (0.64) NOS3NOS1NOS2SLC7A5PTGS1
SCHEMBL22689782 0.86 NOS3 (0.64) NOS3NOS1NOS2SLC7A5PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12359192-B2 Methods and compositions for display of macrocyclic peptides UNIVERSITY OF ROCHESTER (US) 2025-07-15 — — US claimed
US-20250197448-A1 CYCLOPEPTIBODIES AND USES THEREOF UNIVERSITY OF ROCHESTER (US) 2025-06-19 — — US claimed
EP-4490202-A1 CYCLOPEPTIBODIES AND USES THEREOF University of Rochester (US) 2025-01-15 — — EP claimed
WO-2023173084-A9 CYCLOPEPTIBODIES AND USES THEREOF UNIVERSITY OF ROCHESTER (US) 2023-12-14 — — WO claimed
WO-2023173084-A1 CYCLOPEPTIBODIES AND USES THEREOF UNIVERSITY OF ROCHESTER (US) 2023-09-14 — — WO claimed
EP-3087088-B1 METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES UNIV ROCHESTER (US) 2022-05-25 — — EP claimed
US-20200299675-A1 Methods and Compositions for Display of Macrocyclic Peptides UNIVERSITY OF ROCHESTER 2020-09-24 — — US claimed
US-10544191-B2 Methods and compositions for ribosomal synthesis of macrocyclic peptides UNIVERSITY OF ROCHESTER (US) 2020-01-28 — — US claimed
US-20160355552-A1 METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-12-08 — — US claimed
EP-3087088-A2 METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES University Of Rochester (US) 2016-11-02 — — EP claimed
WO-2015100277-A9 METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES UNIVERSITY OF ROCHESTER (US) 2015-10-01 — — WO claimed
WO-2015100277-A2 METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES UNIVERSITY OF ROCHESTER (US) 2015-07-02 — — WO claimed
US-12359192-B2 Methods and compositions for display of macrocyclic peptides UNIVERSITY OF ROCHESTER (US) 2025-07-15 — — US disclosed
US-20250197448-A1 CYCLOPEPTIBODIES AND USES THEREOF UNIVERSITY OF ROCHESTER (US) 2025-06-19 — — US disclosed
EP-4490202-A1 CYCLOPEPTIBODIES AND USES THEREOF University of Rochester (US) 2025-01-15 — — EP disclosed
WO-2023173084-A9 CYCLOPEPTIBODIES AND USES THEREOF UNIVERSITY OF ROCHESTER (US) 2023-12-14 — — WO disclosed
US-4766110-A INHIBITS ANGIOTENSIN CONVERTING ENZYME, HYPOTENSIVE AGENTS RYAN JAMES W (US) 1988-08-23 — — US disclosed
EP-0073143-B1 NOVEL COMPLEX AMIDO AND IMIDO DERIVATIVES OF CARBOXYALKYL PEPTIDES AND THIOETHERS AND ETHERS OF PEPTIDES Ryan, James Walter (US) 1985-11-21 — — EP disclosed
EP-0073143-A2 Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides Ryan, James Walter (US) 1983-03-02 — — EP disclosed
EP-0048159-A2 Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents UNIVERSITY OF MIAMI (US) 1982-03-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12359192-B2 Methods and compositions for display of macrocyclic peptides NGLY1, MICA, MRPL21 NOS3 4493/4885NOS1 4676/4885NOS2 4613/4885
US-10544191-B2 Methods and compositions for ribosomal synthesis of macrocyclic peptides MRPS27, MRPL21, RPLP2 NOS3 4125/4885NOS1 4160/4885NOS2 4279/4885
US-20250197448-A1 CYCLOPEPTIBODIES AND USES THEREOF FCGR3B, FCGRT, FCGR2A NOS3 2600/4885NOS1 2714/4885NOS2 2202/4885
US-20160355552-A1 METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES MRPS27, MRPL21, RPLP2 NOS3 4125/4885NOS1 4160/4885NOS2 4279/4885
US-20200299675-A1 Methods and Compositions for Display of Macrocyclic Peptides SPOUT1, NGLY1, VIP NOS3 4587/4885NOS1 4588/4885NOS2 4663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback